Psychedelic Stock News

Re-Release: Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Psyched Wellness increases its bought deal offering from CAD$3 million to CAD$5.5 million.

TSI EDITOR | 2021-01-25

---

Psychedelics Revolution Gaining Breadth And Momentum

As trading in psychedelic stocks begins to heat up (again), the emerging psychedelic drug industry is growing rapidly -- vertically and horizontally.

TSI EDITOR | 2021-01-25

---

Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

Psyched Wellness announces a CAD$3 million bought deal with units priced at CAD$0.31.

TSI EDITOR | 2021-01-22

---

Numinus Announces Listing of New Warrants

Numinus announces the listing of its latest series of warrants for public trading, under the symbol "NUMI.WS". Warrants have an exercise price of CAD$0.90 and are valid until December 29, 2022.

TSI EDITOR | 2021-01-22

---

Mind Cure Health Inc. Announces an Increase to Previously Announced Bought Deal Public Offering

Mind Cure has upsized its bought deal financing by DOUBLE to CAD$20 million.

TSI EDITOR | 2021-01-22

---

Beckley Foundation: The Major Psychedelics Non-Profit Across The Pond

The UK-based Beckley Foundation is a psychedelics non-profit founded over 20 years ago that is having an increasing impact on the Psychedelics Revolution.

TSI EDITOR | 2021-01-22

---

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

Mind Cure announces a CAD$10 million bought deal financing at a unit price of CAD$0.60. Proceeds will be directed toward product research development and related tech initiatives like its iSTRYM digital therapeutics platform.

TSI EDITOR | 2021-01-21

---

MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

MindMed begins the first Phase 1 clinical trial testing the safety and tolerance of MDMA and LSD in combination.

TSI EDITOR | 2021-01-20

---

Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development

Entheon announces a new partnership to advance its psychedelic drug R&D.

TSI EDITOR | 2021-01-19

---

CYBIN Announces Upsize to Previously Announced Bought Deal Offering

Cybin's bought deal financing has been upsized to CAD$30 million.

TSI EDITOR | 2021-01-19

---

• 1
• 2
• 3
• 4
• ...
• 31
• Next